Scholarly Index
Christophe Benoıst
Harvard University; 72,715 total citations; 524 total publications; best world rank #10
Harvard University
72,715Total citations
524Total publications
141H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes and associated disorders | Lifetime | 14 | US 6 | 99.83 |
| Immune Cell Function and Interaction | Lifetime | 30 | US 21 | 99.95 |
| T-cell and B-cell Immunology | Lifetime | 24 | US 18 | 99.93 |
| Immunotherapy and Immune Responses | Lifetime | 120 | US 70 | 99.78 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 461 | US 268 | 99.17 |
| Single-cell and spatial transcriptomics | Lifetime | 91 | US 50 | 98.27 |
| Pancreatic function and diabetes | Lifetime | 401 | US 187 | 98.79 |
| CAR-T cell therapy research | Lifetime | 698 | US 412 | 98.12 |
| IL-33, ST2, and ILC Pathways | Lifetime | 228 | US 107 | 97.72 |
| Adrenal Hormones and Disorders | Lifetime | 257 | US 102 | 97.21 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 688 | US 248 | 95.99 |
| T-cell and B-cell Immunology | 2021-2025 | 10 | US 8 | 99.26 |
| Immune Cell Function and Interaction | 2021-2025 | 26 | US 16 | 99.38 |
| Single-cell and spatial transcriptomics | 2021-2025 | 635 | US 285 | 89.03 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 291 | US 102 | 87.15 |